Novavax, Inc. (NVAX)
8.855
-0.08
(-0.95%)
USD |
NASDAQ |
Aug 24, 16:00
8.86
0.00 (0.00%)
After-Hours: 20:00
Novavax Total Assets (Quarterly) : 955.58M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 955.58M |
| March 31, 2026 | 1.043B |
| December 31, 2025 | 1.183B |
| September 30, 2025 | 1.180B |
| June 30, 2025 | 1.337B |
| March 31, 2025 | 1.293B |
| December 31, 2024 | 1.603B |
| September 30, 2024 | 1.712B |
| June 30, 2024 | 1.819B |
| March 31, 2024 | 1.354B |
| December 31, 2023 | 1.855B |
| September 30, 2023 | 1.657B |
| June 30, 2023 | 1.685B |
| March 31, 2023 | 1.543B |
| December 31, 2022 | 2.259B |
| September 30, 2022 | 2.267B |
| June 30, 2022 | 2.623B |
| March 31, 2022 | 2.835B |
| December 31, 2021 | 2.577B |
| September 30, 2021 | 2.566B |
| June 30, 2021 | 2.750B |
| March 31, 2021 | 2.608B |
| December 31, 2020 | 1.582B |
| September 30, 2020 | 944.02M |
| June 30, 2020 | 932.23M |
| Date | Value |
|---|---|
| March 31, 2020 | 328.07M |
| December 31, 2019 | 172.96M |
| September 30, 2019 | 164.81M |
| June 30, 2019 | 189.39M |
| March 31, 2019 | 221.32M |
| December 31, 2018 | 207.98M |
| September 30, 2018 | 250.48M |
| June 30, 2018 | 285.81M |
| March 31, 2018 | 276.07M |
| December 31, 2017 | 302.49M |
| September 30, 2017 | 334.08M |
| June 30, 2017 | 355.71M |
| March 31, 2017 | 361.50M |
| December 31, 2016 | 394.30M |
| September 30, 2016 | 459.63M |
| June 30, 2016 | 525.00M |
| March 31, 2016 | 592.51M |
| December 31, 2015 | 386.04M |
| September 30, 2015 | 404.63M |
| June 30, 2015 | 424.70M |
| March 31, 2015 | 438.84M |
| December 31, 2014 | 276.00M |
| September 30, 2014 | 292.51M |
| June 30, 2014 | 311.99M |
| March 31, 2014 | 218.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Moderna, Inc. | 10.96B |
| Merck & Co., Inc. | 129.80B |
| Pfizer Inc. | 201.13B |
| Recursion Pharmaceuticals, Inc. | 1.213B |
| Agenus, Inc. | 172.69M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.146B |
| Shareholders Equity (Quarterly) | -190.71M |
| Debt to Equity Ratio | -1.559 |
| Current Ratio | 2.333 |
| Net Debt Paydown Yield | -0.88% |